Evaluating the effect of givosiran (ALN-AS1) on the rate of porphyria attacks in patients with Acute Hepatic Porphyrias (AHP).
Trial Status: Enrolling
Interested in learning more? Please email us at clinicaltrials@alnylam.com
For more info: ClinicalTrials.gov – NCT03338816